Gilead Sciences, Inc.(GILD)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
GILD | 187.51 B | -57.06x | 10.20% | -10.64% | $-2.65 | -20.68% | 2.23 | 2.25% | $155.38 | $106.44 |
950160.KQ | 1.45 T | - | - | - | - | - | - | - | $149000.00 | $11470.00 |
ABBV | 459.82 B | 73.09x | 10.20% | 9.80% | $3.56 | - | - | 2.71% | $267.47 | $189.40 |
950220.KQ | 17.27 B | - | 45.59% | - | - | -61.03% | 0.20 | - | $5465.00 | $1115.00 |
Peer Valuation & Performance Analysis
Peer group analysis for Gilead Sciences, Inc. (GILD) compared to its primary competitors (including 950160.KQ, ABBV, 950220.KQ) reveals distinct metrics. GILD trades at a valuation discount relative to its competitors, with a P/E ratio of -57.1x versus the peer average of 73.1x (representing a 178% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, GILD's revenue growth of 10.2% lags behind the peer average of 27.9%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of -10.6% is below the peer average of 9.8%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• GILD ranks #0 in P/E ratio, #2 in revenue growth, and #4 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $150.67 | $151.48 | $148.41 | $151.22 | 4,497,700 | +0.37% |
| 2026-09-02 | $150.00 | $152.55 | $148.83 | $149.61 | 4,923,200 | -0.26% |
| 2026-09-01 | $148.52 | $149.96 | $146.92 | $149.92 | 4,868,100 | +0.94% |
| 2026-08-31 | $144.23 | $147.22 | $143.18 | $146.34 | 6,594,700 | +1.46% |
| 2026-08-28 | $149.47 | $149.47 | $144.88 | $145.68 | 3,946,900 | -2.54% |
| 2026-08-27 | $147.30 | $149.11 | $146.01 | $148.86 | 5,014,800 | +1.06% |
| 2026-08-26 | $148.00 | $149.62 | $147.00 | $148.09 | 5,258,300 | +0.06% |
| 2026-08-25 | $146.60 | $148.94 | $145.58 | $148.77 | 4,630,300 | +1.48% |
| 2026-08-24 | $145.93 | $146.84 | $144.59 | $146.74 | 6,182,900 | +0.56% |
| 2026-08-21 | $144.52 | $147.91 | $143.50 | $146.12 | 5,384,300 | +1.11% |
| 2026-08-20 | $146.69 | $146.82 | $143.19 | $143.44 | 7,167,600 | -2.22% |
| 2026-08-19 | $145.10 | $148.97 | $144.30 | $147.60 | 6,738,600 | +1.72% |
| 2026-08-18 | $140.00 | $143.89 | $139.54 | $143.44 | 5,756,500 | +2.46% |
| 2026-08-17 | $138.36 | $139.49 | $136.63 | $138.92 | 3,940,300 | +0.40% |
| 2026-08-14 | $136.81 | $138.43 | $135.91 | $138.36 | 3,406,900 | +1.13% |
Explore More Analysis for GILD
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.